Atom Investors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Atom Investors's BMY Position: Q3 2026 in Review
Atom Investors reduced its Bristol-Myers Squibb (BMY) stake by 43% in Q3 2026, selling an estimated $1.53M and leaving 31,468 shares worth $1.96M. The position accounts for 0.11% of the portfolio, ranked #204.
Atom Investors first reported a position in BMY in Q3 2020 and has held it in 9 quarters since. The position peaked at $7.55M in Q1 2026. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Atom Investors held 31,468 shares of Bristol-Myers Squibb worth $1.96M as of Q3 2026.
- Atom Investors sold 24,170 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.53M.
- Bristol-Myers Squibb made up 0.11% of Atom Investors's portfolio in Q3 2026, its #204 holding.
- Atom Investors first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 9 quarters since.
- Atom Investors's Bristol-Myers Squibb position peaked at $7.55M in Q1 2026.
- 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Atom Investors's 13F filing for Q3 2026, filed 16 Nov 2026.